Search

everythinglearnresearchcommunity

for

Search:↓

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

Hyaluronic acid successfully treated skin atrophy caused by corticosteroid injections.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Reflectance confocal microscopy confirms that yellow dots are signs of damaged hair follicles in alopecia areata.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

EZH2 levels decrease as fetuses develop and are higher in adult skin, which may affect skin growth and repair.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Trichoscopy helps diagnose hairline recession causes in Egyptian women, with androgenetic alopecia being the most common.

Some cats with sudden hair loss and tiredness might have cancer-related alopecia.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Hair transplant surgery effectively treated a specific type of hair loss and is recommended as a primary treatment option.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Inflammation plays a key role in male and female pattern hair loss, and focusing on this could help develop better treatments.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

A man with skin and hair symptoms improved partially with specific treatment.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Inflammation around hair follicles leads to hair loss, and treatments should focus on reducing this inflammation and other factors for effectiveness.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Some people may temporarily lose more hair in certain areas after a hair transplant.

A man had both alopecia areata and lichen planus, which is uncommon.